Analysis of water patterns in protein kinase binding sites

Deregulation of protein kinases is associated with numerous diseases, making them important targets for drug discovery. The majority of drugs target the catalytic site of these proteins, but due to the high level of similarity within the ATP binding sites of protein kinases, it is often difficult to achieve the required pharmacological selectivity. In this study, we describe the identification and subsequent analysis of water patterns in the ATP binding sites of 171 protein kinase structures, comprising 19 different kinases from various branches of the kinome, and demonstrate that structurally similar binding sites often have significantly different water patterns. We show that the observed variations in water patterns of different, but structurally similar kinases can be exploited in the structure‐based design of potent and selective kinase inhibitors. Proteins 2011; © 2011 Wiley‐Liss, Inc.

[1]  S. Wulf,et al.  Amendment history : Corrigendum ( November 2013 ) An anticancer C-Kit kinase inhibitor is reengineered to make it more active and less cardiotoxic , 2018 .

[2]  L. Tong,et al.  Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site , 2002, Nature Structural Biology.

[3]  N. Gray,et al.  Targeting cancer with small molecule kinase inhibitors , 2009, Nature Reviews Cancer.

[4]  A. Doherty,et al.  Soluble 2-substituted aminopyrido[2,3-d]pyrimidin-7-yl ureas. Structure-activity relationships against selected tyrosine kinases and exploration of in vitro and in vivo anticancer activity. , 2001, Journal of medicinal chemistry.

[5]  John Kuriyan,et al.  Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571). , 2001, Cancer research.

[6]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[7]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[8]  P. Seeburg,et al.  Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. , 2000, Science.

[9]  A. Doherty,et al.  Structure-activity relationships for a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors. , 1997, Journal of medicinal chemistry.

[10]  Mike Wood,et al.  4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer. , 2007, Journal of medicinal chemistry.

[11]  C. Humblet,et al.  Development of a binding model to protein tyrosine kinases for substituted pyrido[2,3-d]pyrimidine inhibitors. , 1998, Journal of medicinal chemistry.

[12]  Jeffrey Jie-Lou Liao,et al.  Molecular recognition of protein kinase binding pockets for design of potent and selective kinase inhibitors. , 2007, Journal of medicinal chemistry.

[13]  Caterina Barillari,et al.  Classification of water molecules in protein binding sites. , 2007, Journal of the American Chemical Society.

[14]  D. M. Andrews,et al.  Imidazole piperazines: SAR and development of a potent class of cyclin-dependent kinase inhibitors with a novel binding mode. , 2008, Bioorganic & medicinal chemistry letters.

[15]  S. Hubbard,et al.  Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain , 1998, The EMBO journal.

[16]  L. Kuhn,et al.  Cluster analysis of consensus water sites in thrombin and trypsin shows conservation between serine proteases and contributions to ligand specificity , 1998, Protein science : a publication of the Protein Society.

[17]  Philip M. Dean,et al.  Hydration in drug design. 3. Conserved water molecules at the ligand-binding sites of homologous proteins , 1995, J. Comput. Aided Mol. Des..

[18]  Stefan Knapp,et al.  Insights for the development of specific kinase inhibitors by targeted structural genomics. , 2007, Drug discovery today.

[19]  N. Gray,et al.  Rational design of inhibitors that bind to inactive kinase conformations , 2006, Nature chemical biology.

[20]  W. Punch,et al.  Predicting conserved water-mediated and polar ligand interactions in proteins using a K-nearest-neighbors genetic algorithm. , 1997, Journal of molecular biology.

[21]  G. Klebe,et al.  From the Similarity Analysis of Protein Cavities to the Functional Classification of Protein Families Using Cavbase , 2006, Journal of Molecular Biology.

[22]  Ricardo L. Mancera,et al.  WaterScore: a novel method for distinguishing between bound and displaceable water molecules in the crystal structure of the binding site of protein-ligand complexes , 2003, Journal of molecular modeling.

[23]  Donald Hamelberg,et al.  The role of conserved water molecules in the catalytic domain of protein kinases , 2009, Proteins.

[24]  Philip M. Dean,et al.  Hydration in drug design. 2. Influence of local site surface shape on water binding , 1995, J. Comput. Aided Mol. Des..

[25]  Richard M. Jackson,et al.  Binding Site Similarity Analysis for the Functional Classification of the Protein Kinase Family , 2009, J. Chem. Inf. Model..

[26]  Anastassis Perrakis,et al.  Developments in the CCP4 molecular-graphics project. , 2004, Acta crystallographica. Section D, Biological crystallography.

[27]  J. Kuriyan,et al.  The Conformational Plasticity of Protein Kinases , 2002, Cell.

[28]  Philip M. Dean,et al.  Hydration in drug design. 1. Multiple hydrogen-bonding features of water molecules in mediating protein-ligand interactions , 1995, J. Comput. Aided Mol. Des..

[29]  Eyke Hüllermeier,et al.  Functional Classification of Protein Kinase Binding Sites Using Cavbase , 2007, ChemMedChem.

[30]  Didier Rognan,et al.  sc-PDB: an Annotated Database of Druggable Binding Sites from the Protein Data Bank , 2006, J. Chem. Inf. Model..

[31]  Serge X. Cohen,et al.  Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7 , 2008, Nature Protocols.

[32]  L. Johnson,et al.  Protein Kinase Inhibitors: Insights into Drug Design from Structure , 2004, Science.

[33]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[34]  E. Kellenberger,et al.  A simple and fuzzy method to align and compare druggable ligand‐binding sites , 2008, Proteins.

[35]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[36]  Kevan M Shokat,et al.  Features of selective kinase inhibitors. , 2005, Chemistry & biology.

[37]  D. Barford,et al.  Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF , 2004, Cell.

[38]  W. L. Jorgensen,et al.  Energetics of displacing water molecules from protein binding sites: consequences for ligand optimization. , 2009, Journal of the American Chemical Society.

[39]  L. Meijer,et al.  An integrated computational approach to the phenomenon of potent and selective inhibition of aurora kinases B and C by a series of 7-substituted indirubins. , 2007, Journal of medicinal chemistry.

[40]  W. Sherman,et al.  Understanding Kinase Selectivity Through Energetic Analysis of Binding Site Waters , 2010, ChemMedChem.

[41]  W. Denny,et al.  Synthesis and Structure−Activity Relationships of Soluble 7-Substituted 3-(3,5-Dimethoxyphenyl)-1,6-naphthyridin-2-amines and Related Ureas as Dual Inhibitors of the Fibroblast Growth Factor Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinases , 2005 .